intermittent fasting glp-1 + Injections: Smart or Dangerous? | Blog Intermittent fasting and GLP-1: combining

Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity

This simple yet effective drip replenishes fluids and electrolytes, ensuring your body stays refreshed and rejuvenated

They propose based on rodent and monkey studies that this kind of molecule, when administered at high enough doses, may result in weight loss comparable to the weight loss seen with drugs that include GLP-1 as a target, and without the tolerability issues like nausea and vomiting that often come with the approved treatments, according to a peer-reviewed draft paper published this week

References Andreazza AC, Cassini C, Rosa AR et al (2007) Serum S100B and antioxidant enzymes in bipolar patients

Yes, GLP-1based medications have received FDA approval for weight loss treatment